TY - JOUR
T1 - Impact of COVID-19 and factors associated with long COVID and COVID-19 vaccine uptake in people with HIV in the United Kingdom
T2 - Results from Positive Voices 2022
AU - the PV2022 Study Group
AU - Nakagawa, F.
AU - Palich, R.
AU - Kall, M.
AU - Sewell, J.
AU - Smith, C.
AU - Kelly, C.
AU - Kitt, H.
AU - Pelchen-Matthews, A.
AU - Aghaizu, A.
AU - Sparrowhawk, A.
AU - Mackie, N.
AU - Djuretic, T.
AU - Schoeman, S.
AU - Humphreys, C.
AU - Lipman, M.
AU - Lampe, F. C.
AU - Rodger, A. J.
AU - Sullivan, Ann
AU - Jones, Rachel
AU - Hassan, Mohammed
AU - Miodragovic, Serge
AU - Sullivan, Ann
AU - Tittle, Victoria
AU - Hassan, Mohammed
AU - Miodragovic, Serge
AU - Edwards, Sarah
AU - Rosenvinge, Melanie
AU - Mascagni, Allison
AU - Harrington, Rosa
AU - Adade, Claudia
AU - Clarke, Emily
AU - Mason, Sandra
AU - Clarke, Emily
AU - Priest, Elaine
AU - Clarke, Emily
AU - Mason, Sandra
AU - Clarke, Emily
AU - Priest, Elaine
AU - Clarke, Emily
AU - Martin, Melissa
AU - Umaipalan, Athavan
AU - Field, Julie
AU - Woodward, Clare
AU - Williams, Felicity
AU - Hamlyn, Liz
AU - Campbell, Lucy
AU - Taylor, Steve
AU - Gilleran, Gerry
AU - Kaur, Satwant
AU - Harwood, Samantha
N1 - Publisher Copyright: © 2025 The Author(s). HIV Medicine published by John Wiley & Sons Ltd on behalf of British HIV Association.
PY - 2025/6
Y1 - 2025/6
N2 - Objectives: We assessed the impact of COVID-19, and the prevalence and factors associated with a history of COVID-19 infection, long COVID and incomplete COVID-19 vaccine uptake among people with HIV. Methods: Positive Voices 2022 is a questionnaire study of people accessing HIV care in the United Kingdom (March 2022–April 2023). Logistic regression assessed factors associated with a history of COVID-19 (previous positive test), long COVID among those with a history of COVID-19 (ongoing symptoms, with COVID-19 onset >3 months previously) and incomplete COVID-19 vaccine uptake (less than three doses of vaccine), adjusted for: age; gender; ethnicity; and year of HIV diagnosis. Results: In all, 4188 participants were included. Commonly reported negative impacts of the pandemic were on social contact (44% of participants), mental health (30%), healthcare access (26%) and financial security (25%). Overall, 2068 of 4188 (49.4%) participants had a history of COVID-19. Of these, 10.8% met criteria for long COVID, associated with female gender, unemployment, financial hardship, earlier HIV diagnosis date, diabetes diagnosis, asthma/chronic obstructive pulmonary disease diagnosis, obesity and symptoms of depression and anxiety. Overall, 95.8% reported having at least one vaccine dose, but 649 (15.7%) participants had incomplete vaccine uptake, associated with younger age, female gender, Black African ethnicity, lower education, financial hardship, unemployment, multioccupancy household, more recent HIV diagnosis, detectable HIV viral load and symptoms of depression and anxiety. Conclusions: About half of participants had a history of COVID-19, of whom 11% had persistent symptoms (long COVID). COVID-19 vaccine uptake was high, but incomplete uptake was apparent for 16% of participants and was more common among women, younger people, Black African individuals and those with socio-economic disadvantage.
AB - Objectives: We assessed the impact of COVID-19, and the prevalence and factors associated with a history of COVID-19 infection, long COVID and incomplete COVID-19 vaccine uptake among people with HIV. Methods: Positive Voices 2022 is a questionnaire study of people accessing HIV care in the United Kingdom (March 2022–April 2023). Logistic regression assessed factors associated with a history of COVID-19 (previous positive test), long COVID among those with a history of COVID-19 (ongoing symptoms, with COVID-19 onset >3 months previously) and incomplete COVID-19 vaccine uptake (less than three doses of vaccine), adjusted for: age; gender; ethnicity; and year of HIV diagnosis. Results: In all, 4188 participants were included. Commonly reported negative impacts of the pandemic were on social contact (44% of participants), mental health (30%), healthcare access (26%) and financial security (25%). Overall, 2068 of 4188 (49.4%) participants had a history of COVID-19. Of these, 10.8% met criteria for long COVID, associated with female gender, unemployment, financial hardship, earlier HIV diagnosis date, diabetes diagnosis, asthma/chronic obstructive pulmonary disease diagnosis, obesity and symptoms of depression and anxiety. Overall, 95.8% reported having at least one vaccine dose, but 649 (15.7%) participants had incomplete vaccine uptake, associated with younger age, female gender, Black African ethnicity, lower education, financial hardship, unemployment, multioccupancy household, more recent HIV diagnosis, detectable HIV viral load and symptoms of depression and anxiety. Conclusions: About half of participants had a history of COVID-19, of whom 11% had persistent symptoms (long COVID). COVID-19 vaccine uptake was high, but incomplete uptake was apparent for 16% of participants and was more common among women, younger people, Black African individuals and those with socio-economic disadvantage.
KW - COVID-19
KW - HIV
KW - long COVID
KW - vaccination
UR - https://www.scopus.com/pages/publications/105004362377
U2 - 10.1111/hiv.70026
DO - 10.1111/hiv.70026
M3 - Article
C2 - 40313005
SN - 1464-2662
VL - 26
SP - 923
EP - 939
JO - HIV Medicine
JF - HIV Medicine
IS - 6
ER -